Known Prognostic Models Fail to Predict Outcomes for Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis. - Gilbert JS; Connor M; Bosma G; Zhang J; McMahon CM; Amaya ML; Gutman J; Schwartz M; Kent A; Abbott D; Pollyea DA (American journal of hematology, 2025)